Cargando…
Patient‐reported ability to walk 4 m and to wash: New clinical endpoints and predictors of survival in patients with pre‐terminal cancer
BACKGROUND: Maintaining the ability to perform self‐care is a critical goal in patients with cancer. We assessed whether the patient‐reported ability to walk 4 m and wash oneself predict survival in patients with pre‐terminal cancer. METHODS: We performed a prospective observational study on 169 con...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10401535/ https://www.ncbi.nlm.nih.gov/pubmed/37222009 http://dx.doi.org/10.1002/jcsm.13247 |
_version_ | 1785084686247133184 |
---|---|
author | Anker, Markus S. Lena, Alessia Roeland, Eric J. Porthun, Jan Schmitz, Sebastian Hadzibegovic, Sara Sikorski, Philipp Wilkenshoff, Ursula Fröhlich, Ann‐Kathrin Ramer, Luisa Valentina Rose, Matthias Eucker, Jan Rassaf, Tienush Totzeck, Matthias Lehmann, Lorenz H. von Haehling, Stephan Coats, Andrew J.S. Friede, Tim Butler, Javed Anker, Stefan D. Riess, Hanno Landmesser, Ulf Bullinger, Lars Keller, Ulrich Ahn, Johann |
author_facet | Anker, Markus S. Lena, Alessia Roeland, Eric J. Porthun, Jan Schmitz, Sebastian Hadzibegovic, Sara Sikorski, Philipp Wilkenshoff, Ursula Fröhlich, Ann‐Kathrin Ramer, Luisa Valentina Rose, Matthias Eucker, Jan Rassaf, Tienush Totzeck, Matthias Lehmann, Lorenz H. von Haehling, Stephan Coats, Andrew J.S. Friede, Tim Butler, Javed Anker, Stefan D. Riess, Hanno Landmesser, Ulf Bullinger, Lars Keller, Ulrich Ahn, Johann |
author_sort | Anker, Markus S. |
collection | PubMed |
description | BACKGROUND: Maintaining the ability to perform self‐care is a critical goal in patients with cancer. We assessed whether the patient‐reported ability to walk 4 m and wash oneself predict survival in patients with pre‐terminal cancer. METHODS: We performed a prospective observational study on 169 consecutive hospitalized patients with cancer (52% female, 64 ± 12 years) and an estimated 1–12 months prognosis at an academic, inpatient palliative care unit. Patients answered functional questions for ‘today’, ‘last week’, and ‘last month’, performed patient‐reported outcomes (PROs), and physical function assessments. RESULTS: Ninety‐two (54%) patients reported the ability to independently walk 4 m and 100 (59%) to wash ‘today’. The median number of days patients reported the ability to walk 4 m and wash were 6 (IQR 0–7) and 7 (0–7) days (‘last week’); and 27 (5–30) and 26 (10–30) days (‘last month’). In the last week, 32% of patients were unable to walk 4 m on every day and 10% could walk on 1–3 days; 30% were unable to wash on every day and 10% could wash on 1–3 days. In the last months, 14% of patients were unable to walk 4 m on every day and 10% could only walk on 1–10 days; 12% were unable to wash on every day and 11% could wash on 1–10 days. In patients who could walk ‘today’ average 4 m gait speed was 0.78 ± 0.28 m/s. Patients who reported impaired walking and washing experienced more symptoms (dyspnoea, exertion, and oedema) and decreased physical function (higher Eastern Cooperative Oncology Group Performance Status, and lower Karnofsky Performance Status and hand‐grip strength [unable vs. able to walk ‘today’: 205 ± 87 vs. 252 ± 78 Newton, P = 0.001; unable vs. able to wash ‘today’: 204 ± 86 vs. 250 ± 80 Newton, P = 0.001]). During the 27 months of observation, 152 (90%) patients died (median survival 46 days). In multivariable Cox proportional hazards regression analyses, all tested parameters were independent predictors of survival: walking 4 m ‘today’ (HR 0.63, P = 0.015), ‘last week’ (per 1 day: HR 0.93, P = 0.011), ‘last month’ (per 1 day: HR 0.98, P = 0.012), 4 m gait speed (per 1 m/s: HR 0.45, P = 0.002), and washing ‘today’ (HR 0.67, P = 0.024), ‘last week (per 1 day HR 0.94, p=0.019), and ‘last month’ (per 1 day HR 0.99, P = 0.040). Patients unable to walk and wash experienced the shortest survival and most reduced functional status. CONCLUSIONS: In patients with pre‐terminal cancer, the self‐reported ability to walk 4 m and wash were independent predictors of survival and associated with decreased functional status. |
format | Online Article Text |
id | pubmed-10401535 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-104015352023-08-05 Patient‐reported ability to walk 4 m and to wash: New clinical endpoints and predictors of survival in patients with pre‐terminal cancer Anker, Markus S. Lena, Alessia Roeland, Eric J. Porthun, Jan Schmitz, Sebastian Hadzibegovic, Sara Sikorski, Philipp Wilkenshoff, Ursula Fröhlich, Ann‐Kathrin Ramer, Luisa Valentina Rose, Matthias Eucker, Jan Rassaf, Tienush Totzeck, Matthias Lehmann, Lorenz H. von Haehling, Stephan Coats, Andrew J.S. Friede, Tim Butler, Javed Anker, Stefan D. Riess, Hanno Landmesser, Ulf Bullinger, Lars Keller, Ulrich Ahn, Johann J Cachexia Sarcopenia Muscle Original Articles BACKGROUND: Maintaining the ability to perform self‐care is a critical goal in patients with cancer. We assessed whether the patient‐reported ability to walk 4 m and wash oneself predict survival in patients with pre‐terminal cancer. METHODS: We performed a prospective observational study on 169 consecutive hospitalized patients with cancer (52% female, 64 ± 12 years) and an estimated 1–12 months prognosis at an academic, inpatient palliative care unit. Patients answered functional questions for ‘today’, ‘last week’, and ‘last month’, performed patient‐reported outcomes (PROs), and physical function assessments. RESULTS: Ninety‐two (54%) patients reported the ability to independently walk 4 m and 100 (59%) to wash ‘today’. The median number of days patients reported the ability to walk 4 m and wash were 6 (IQR 0–7) and 7 (0–7) days (‘last week’); and 27 (5–30) and 26 (10–30) days (‘last month’). In the last week, 32% of patients were unable to walk 4 m on every day and 10% could walk on 1–3 days; 30% were unable to wash on every day and 10% could wash on 1–3 days. In the last months, 14% of patients were unable to walk 4 m on every day and 10% could only walk on 1–10 days; 12% were unable to wash on every day and 11% could wash on 1–10 days. In patients who could walk ‘today’ average 4 m gait speed was 0.78 ± 0.28 m/s. Patients who reported impaired walking and washing experienced more symptoms (dyspnoea, exertion, and oedema) and decreased physical function (higher Eastern Cooperative Oncology Group Performance Status, and lower Karnofsky Performance Status and hand‐grip strength [unable vs. able to walk ‘today’: 205 ± 87 vs. 252 ± 78 Newton, P = 0.001; unable vs. able to wash ‘today’: 204 ± 86 vs. 250 ± 80 Newton, P = 0.001]). During the 27 months of observation, 152 (90%) patients died (median survival 46 days). In multivariable Cox proportional hazards regression analyses, all tested parameters were independent predictors of survival: walking 4 m ‘today’ (HR 0.63, P = 0.015), ‘last week’ (per 1 day: HR 0.93, P = 0.011), ‘last month’ (per 1 day: HR 0.98, P = 0.012), 4 m gait speed (per 1 m/s: HR 0.45, P = 0.002), and washing ‘today’ (HR 0.67, P = 0.024), ‘last week (per 1 day HR 0.94, p=0.019), and ‘last month’ (per 1 day HR 0.99, P = 0.040). Patients unable to walk and wash experienced the shortest survival and most reduced functional status. CONCLUSIONS: In patients with pre‐terminal cancer, the self‐reported ability to walk 4 m and wash were independent predictors of survival and associated with decreased functional status. John Wiley and Sons Inc. 2023-05-24 /pmc/articles/PMC10401535/ /pubmed/37222009 http://dx.doi.org/10.1002/jcsm.13247 Text en © 2023 The Authors. Journal of Cachexia, Sarcopenia and Muscle published by John Wiley & Sons Ltd on behalf of Society on Sarcopenia, Cachexia and Wasting Disorders. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Original Articles Anker, Markus S. Lena, Alessia Roeland, Eric J. Porthun, Jan Schmitz, Sebastian Hadzibegovic, Sara Sikorski, Philipp Wilkenshoff, Ursula Fröhlich, Ann‐Kathrin Ramer, Luisa Valentina Rose, Matthias Eucker, Jan Rassaf, Tienush Totzeck, Matthias Lehmann, Lorenz H. von Haehling, Stephan Coats, Andrew J.S. Friede, Tim Butler, Javed Anker, Stefan D. Riess, Hanno Landmesser, Ulf Bullinger, Lars Keller, Ulrich Ahn, Johann Patient‐reported ability to walk 4 m and to wash: New clinical endpoints and predictors of survival in patients with pre‐terminal cancer |
title | Patient‐reported ability to walk 4 m and to wash: New clinical endpoints and predictors of survival in patients with pre‐terminal cancer |
title_full | Patient‐reported ability to walk 4 m and to wash: New clinical endpoints and predictors of survival in patients with pre‐terminal cancer |
title_fullStr | Patient‐reported ability to walk 4 m and to wash: New clinical endpoints and predictors of survival in patients with pre‐terminal cancer |
title_full_unstemmed | Patient‐reported ability to walk 4 m and to wash: New clinical endpoints and predictors of survival in patients with pre‐terminal cancer |
title_short | Patient‐reported ability to walk 4 m and to wash: New clinical endpoints and predictors of survival in patients with pre‐terminal cancer |
title_sort | patient‐reported ability to walk 4 m and to wash: new clinical endpoints and predictors of survival in patients with pre‐terminal cancer |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10401535/ https://www.ncbi.nlm.nih.gov/pubmed/37222009 http://dx.doi.org/10.1002/jcsm.13247 |
work_keys_str_mv | AT ankermarkuss patientreportedabilitytowalk4mandtowashnewclinicalendpointsandpredictorsofsurvivalinpatientswithpreterminalcancer AT lenaalessia patientreportedabilitytowalk4mandtowashnewclinicalendpointsandpredictorsofsurvivalinpatientswithpreterminalcancer AT roelandericj patientreportedabilitytowalk4mandtowashnewclinicalendpointsandpredictorsofsurvivalinpatientswithpreterminalcancer AT porthunjan patientreportedabilitytowalk4mandtowashnewclinicalendpointsandpredictorsofsurvivalinpatientswithpreterminalcancer AT schmitzsebastian patientreportedabilitytowalk4mandtowashnewclinicalendpointsandpredictorsofsurvivalinpatientswithpreterminalcancer AT hadzibegovicsara patientreportedabilitytowalk4mandtowashnewclinicalendpointsandpredictorsofsurvivalinpatientswithpreterminalcancer AT sikorskiphilipp patientreportedabilitytowalk4mandtowashnewclinicalendpointsandpredictorsofsurvivalinpatientswithpreterminalcancer AT wilkenshoffursula patientreportedabilitytowalk4mandtowashnewclinicalendpointsandpredictorsofsurvivalinpatientswithpreterminalcancer AT frohlichannkathrin patientreportedabilitytowalk4mandtowashnewclinicalendpointsandpredictorsofsurvivalinpatientswithpreterminalcancer AT ramerluisavalentina patientreportedabilitytowalk4mandtowashnewclinicalendpointsandpredictorsofsurvivalinpatientswithpreterminalcancer AT rosematthias patientreportedabilitytowalk4mandtowashnewclinicalendpointsandpredictorsofsurvivalinpatientswithpreterminalcancer AT euckerjan patientreportedabilitytowalk4mandtowashnewclinicalendpointsandpredictorsofsurvivalinpatientswithpreterminalcancer AT rassaftienush patientreportedabilitytowalk4mandtowashnewclinicalendpointsandpredictorsofsurvivalinpatientswithpreterminalcancer AT totzeckmatthias patientreportedabilitytowalk4mandtowashnewclinicalendpointsandpredictorsofsurvivalinpatientswithpreterminalcancer AT lehmannlorenzh patientreportedabilitytowalk4mandtowashnewclinicalendpointsandpredictorsofsurvivalinpatientswithpreterminalcancer AT vonhaehlingstephan patientreportedabilitytowalk4mandtowashnewclinicalendpointsandpredictorsofsurvivalinpatientswithpreterminalcancer AT coatsandrewjs patientreportedabilitytowalk4mandtowashnewclinicalendpointsandpredictorsofsurvivalinpatientswithpreterminalcancer AT friedetim patientreportedabilitytowalk4mandtowashnewclinicalendpointsandpredictorsofsurvivalinpatientswithpreterminalcancer AT butlerjaved patientreportedabilitytowalk4mandtowashnewclinicalendpointsandpredictorsofsurvivalinpatientswithpreterminalcancer AT ankerstefand patientreportedabilitytowalk4mandtowashnewclinicalendpointsandpredictorsofsurvivalinpatientswithpreterminalcancer AT riesshanno patientreportedabilitytowalk4mandtowashnewclinicalendpointsandpredictorsofsurvivalinpatientswithpreterminalcancer AT landmesserulf patientreportedabilitytowalk4mandtowashnewclinicalendpointsandpredictorsofsurvivalinpatientswithpreterminalcancer AT bullingerlars patientreportedabilitytowalk4mandtowashnewclinicalendpointsandpredictorsofsurvivalinpatientswithpreterminalcancer AT kellerulrich patientreportedabilitytowalk4mandtowashnewclinicalendpointsandpredictorsofsurvivalinpatientswithpreterminalcancer AT ahnjohann patientreportedabilitytowalk4mandtowashnewclinicalendpointsandpredictorsofsurvivalinpatientswithpreterminalcancer |